A novel agglutination method for screening of HIV and HCV antibody testing with 5-microliters reagents: reduction of cost and time with high sensitivity.
Mizui
M
M
Hiroshima Red Cross Blood Center, Japan.
Moriya
T
T
Yoshizawa
H
H
Kondo
M
M
Saito
T
T
Imai
M
M
Nishioka
K
K
D000372:Agglutination Tests / Q000191:economics; D000956:Antigens, Viral / Q000276:immunology; D003365:Costs and Cost Analysis; D005780:Gelatin; D015483:HIV Antibodies / Q000097:blood*; D015488:HIV Antigens / Q000276:immunology; D015658:HIV Infections / Q000097:blood / Q000517:prevention & control*; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000517:prevention & control*; D018937:Hepatitis C Antibodies; D006801:Humans; D007202:Indicators and Reagents; D008403:Mass Screening / Q000379:methods*; D008832:Microchemistry; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013996:Time and Motion Studies
D000956:Antigens, Viral; D015483:HIV Antibodies; D015488:HIV Antigens; D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D007202:Indicators and Reagents; D005780:Gelatin